December 19, 2016 04:20 PM ESTUpdated December 20, 07:44 AM
People

Sur­prise! Bio­gen goes with com­mer­cial chief Vounatsos in re­plac­ing CEO Scan­gos

John Carroll

Editor & Founder

Bio­gen is pro­mot­ing chief com­mer­cial of­fi­cer Michel Vounatsos as its new CEO, re­plac­ing out­go­ing CEO George Scan­gos and fo­cus­ing di­rect­ly on its late-stage pipeline …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Out­look's shares crash as wet AMD drug flunks Phase 3 test

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times